Inari Medical Newsroom

CCORF Maintains Inari Medical(NARI.US) With Buy Rating, Maintains Target Price $71

Moomoo NewsAug 2 07:35 ET

Baird Maintains Inari Medical(NARI.US) With Buy Rating, Cuts Target Price to $63

Moomoo NewsAug 1 03:32 ET

Morgan Stanley Maintains Inari Medical(NARI.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsJul 31 10:36 ET

Bank of America Securities Remains a Buy on Inari Medical (NARI)

TipRanksJul 31 10:07 ET

A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $55 to $71

Moomoo NewsJul 31 09:19 ET

Truist Adjusts Inari Medical's Price Target to $55 From $60, Maintains Hold Rating

MT NewswiresJul 31 09:11 ET

Inari Medical Price Target Raised to $71.00/Share From $55.00 by Canaccord Genuity

Dow JonesJul 31 09:03 ET

Inari Medical (NARI) Gets a Buy From Morgan Stanley

TipRanksJul 31 08:50 ET

Baird Maintains Outperform on Inari Medical, Lowers Price Target to $63

BenzingaJul 31 08:45 ET

Inari Medical Analyst Ratings

BenzingaJul 31 08:23 ET

Analysts' Top Healthcare Picks: Stryker (SYK), Inari Medical (NARI)

TipRanksJul 31 07:16 ET

Inari Medical: A Cautious Hold Amid Mixed Financial Results and Executive Changes

TipRanksJul 31 06:39 ET

Inari Medical's Strong Q2 Performance and Positive 2024 Outlook Merit Buy Rating

TipRanksJul 31 06:27 ET

Inari Medical Analyst Ratings

BenzingaJul 25 08:17 ET

William Blair Initiates Inari Medical(NARI.US) With Buy Rating

Moomoo NewsJul 25 07:50 ET

Inari Medical Analyst Ratings

BenzingaJul 18 06:07 ET

Inari Medical Analyst Ratings

BenzingaJul 16 09:47 ET

Truist Securities Maintains Hold on Inari Medical, Raises Price Target to $60

BenzingaJul 16 09:47 ET

Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating

MT NewswiresJul 15 06:59 ET

Analysts Offer Insights on Healthcare Companies: Inari Medical (NARI), Biogen (BIIB) and SOPHiA GENETICS (SOPH)

TipRanksMay 28 06:54 ET